Cargando…
Towards a Systems Immunology Approach to Unravel Responses to Cancer Immunotherapy
Immunotherapy, particularly immune checkpoint blockade and chimeric antigen receptor (CAR)-T cells, holds a great promise against cancer. These treatments have markedly improved survival in solid as well as in hematologic tumors previously considered incurable. However, durable responses occur in a...
Autores principales: | Bracci, Laura, Fragale, Alessandra, Gabriele, Lucia, Moschella, Federica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649803/ https://www.ncbi.nlm.nih.gov/pubmed/33193392 http://dx.doi.org/10.3389/fimmu.2020.582744 |
Ejemplares similares
-
Editorial: Decoding immunologic complex systems in cancer: the cutting-edge technologies revolutionizing cancer immunology and immunotherapy
por: Li, Hu, et al.
Publicado: (2023) -
Immunological and Translational Aspects of NK Cell-Based Antitumor Immunotherapies
por: Shevtsov, Maxim, et al.
Publicado: (2016) -
Immunological Approaches Towards Cancer and Inflammation: A Cross Talk
por: Qu, Xinglong, et al.
Publicado: (2018) -
Regulatory Dendritic Cells for Immunotherapy in Immunologic Diseases
por: Gordon, John R., et al.
Publicado: (2014) -
Inflammasomes: Emerging Central Players in Cancer Immunology and Immunotherapy
por: Karan, Dev
Publicado: (2018)